Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biohaven Pursues Best-In-Class Sales With Nurtec ODT’s Migraine Prevention Approval
Oral CGRP Inhibitor Is First For Dual Use
Jun 02 2021
•
By
Mandy Jackson
Nurtec was approved for acute treatment of migraine before it was cleared for migraine prevention • Source: Alamy
More from New Products
More from Scrip